These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18399058)

  • 21. Mammographic breast density as an intermediate phenotype for breast cancer.
    Boyd NF; Rommens JM; Vogt K; Lee V; Hopper JL; Yaffe MJ; Paterson AD
    Lancet Oncol; 2005 Oct; 6(10):798-808. PubMed ID: 16198986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
    Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
    Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment.
    Gram IT; Ursin G; Spicer DV; Pike MC
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1117-20. PubMed ID: 11700258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
    Roubidoux MA; Bailey JE; Wray LA; Helvie MA
    Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Breast density: a major parameter to follow during hormone replacement therapy].
    Gairard B; Guldenfels C; Haehnel P; Mathelin C
    Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study.
    Stuedal A; Ursin G; Veierød MB; Bremnes Y; Reseland JE; Drevon CA; Gram IT
    Breast Cancer Res; 2006; 8(5):R55. PubMed ID: 17010200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
    Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
    Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
    Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
    Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.
    Atkinson C; Warren R; Bingham SA; Day NE
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):863-6. PubMed ID: 10548313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body size, mammographic density, and breast cancer risk.
    Boyd NF; Martin LJ; Sun L; Guo H; Chiarelli A; Hislop G; Yaffe M; Minkin S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2086-92. PubMed ID: 17119032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors contributing to mammography failure in women aged 40-49 years.
    Buist DS; Porter PL; Lehman C; Taplin SH; White E
    J Natl Cancer Inst; 2004 Oct; 96(19):1432-40. PubMed ID: 15467032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specificity and sensitivity of mammographic screening.
    Patella A; Marziani R; Schippa A; Benedetti S; Mossa S; Mossa B
    Eur J Gynaecol Oncol; 2005; 26(5):485-90. PubMed ID: 16285562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between mammographic breast density and bone mineral density in the study of women's health across the nation.
    Crandall CJ; Zheng Y; Karlamangla A; Sternfeld B; Habel LA; Oestreicher N; Johnston J; Cauley JA; Greendale GA
    Ann Epidemiol; 2007 Aug; 17(8):575-83. PubMed ID: 17532645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormones and mammographic breast density.
    Warren R
    Maturitas; 2004 Sep; 49(1):67-78. PubMed ID: 15351098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study.
    McNicholas MM; Heneghan JP; Milner MH; Tunney T; Hourihane JB; MacErlaine DP
    AJR Am J Roentgenol; 1994 Aug; 163(2):311-5. PubMed ID: 8037021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors.
    Palomares MR; Machia JR; Lehman CD; Daling JR; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1324-30. PubMed ID: 16835331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
    Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
    Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammographic density, breast cancer risk and risk prediction.
    Vachon CM; van Gils CH; Sellers TA; Ghosh K; Pruthi S; Brandt KR; Pankratz VS
    Breast Cancer Res; 2007; 9(6):217. PubMed ID: 18190724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.